STREAMING NOW: Watch Now

CDC, FDA Looking Into Risk Of Nerve Complication After Johnson & Johnson COVID-19 Vaccine

Not Available

Posted: Jul 14, 2021 3:12 PM


The US Food and Drug Administration updated the label on Johnson & Johnson's coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication known as Guillain-Barré syndrome.

While the FDA said it had not established the vaccine could cause the syndrome, it noted an increase in reports of the sometimes paralyzing condition.

"Today, the FDA is announcing revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination," it said in a statement sent to CNN.

"Reports of adverse events following use of the Janssen COVID-19 Vaccine under emergency use authorization suggest an increased risk of Guillain-Barré syndrome during the 42 days following vaccination," the updated label reads.

"Although the available evidence suggests an association between the Janssen vaccine and increased risk of GBS, it is insufficient to establish a causal relationship. No similar signal has been identified with the Moderna and Pfizer-BioNTech COVID-19 vaccines," the label adds.

The FDA said 100 preliminary reports of Guillain-Barré syndrome had been filed with the US government's Vaccine Adverse Event Reporting System, out of 12.8 million Janssen vaccines given.

"Guillain Barré syndrome (a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis) has occurred in some people who have received the Janssen COVID-19 Vaccine," the FDA says in the label update for patients and caregivers.

"In most of these people, symptoms began within 42 days following receipt of the Janssen COVID-19 Vaccine. The chance of having this occur is very low," it adds.

People should seek medical attention if they notice symptoms such as weakness or tingling in the arms and legs, especially if it spreads, after receiving a vaccine, the FDA said.

Other telltale symptoms include difficulty walking, speaking, chewing or swallowing; double vision; and bowel or bladder control problems.

The FDA said 95 of the 100 reports of GBS involved people who needed hospitalization, and one person died.

"Each year in the United States, an estimated 3,000 to 6,000 people develop GBS. Most people fully recover from the disorder," the agency added.

"GBS has also been observed at an increased rate associated with certain vaccines, including certain seasonal influenza vaccines and a vaccine to prevent shingles.

Johnson & Johnson confirmed it was talking to the US Centers for Disease Control and Prevention and FDA about the issue.

"We have been in discussions with the U.S. Food and Drug Administration and other regulators about rare cases of the neurological disorder, Guillain-BarreÌ syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine," the company said in a brief statement.

"The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree," it added.

Even if the vaccine does raise the risk of the syndrome, it's still better to get vaccinated against the coronavirus, the CDC stressed.

So did Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

"You're always going to find some adverse event associated with vaccination," Fauci told CNN's Chris Cuomo.

"When you vaccinate tens of millions of people, you will always find a rare event. You've got make a decision -- does the benefit outweigh the unusual risk of an adverse event? Thus far with the vaccines, it's always been decided that the benefit of the vaccine outweighs the risk of an adverse event."

The CDC and FDA are monitoring cases of the syndrome.

"GBS is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness or, in the most severe cases, paralysis. Each year in the United States, an estimated 3,000 to 6,000 people develop GBS; it is typically triggered by a respiratory or gastrointestinal infection. Most people fully recover from GBS," a CDC spokesperson told CNN.

"Reports of GBS after receipt of the J&J/Janssen COVID-19 Vaccine in the Vaccine Adverse Event Reporting System (VAERS) are rare, but do likely indicate a small possible risk of this side effect following this vaccine," the spokesperson added.

The spokesperson said the CDC's Advisory Committee on Immunization Practices would discuss the matter in an upcoming meeting.

"In the United States, nearly all COVID-19 hospitalizations and deaths are now occurring in unvaccinated people. The risk of severe adverse events after COVID-19 vaccination remains rare. Everyone age 12 years and older is recommended to receive a COVID-19 vaccine," the statement said.

It's yet another setback for the J&J vaccine, which has been bedeviled by problems.

The CDC and FDA briefly paused use of the Johnson & Johnson vaccine earlier this year because of a risk of a rare type of blood clotting complication but lifted the pause in April after determining the risk was low and the condition was treatable. The vaccine's label was updated to warn about the risk.

Manufacturing was delayed by a mixup at a contract vaccine plant run by Emergent BioSolutions in Baltimore that ruined millions of potential Johnson & Johnson doses earlier this year.

J&J's Janssen vaccine was the third vaccine to win emergency use authorization from the FDA, after Pfizer's and Moderna's. According to the CDC, 84.6 million Americans have received both doses of Pfizer's vaccine; 62 million are fully vaccinated with Moderna's and 12.7 million with J&J's one-dose regimen.

The-CNN-Wire
™ & © 2021 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.

Mississippi Coronavirus Cases

Data is updated nightly.

Cases: 498560

Reported Deaths: 9939
CountyCasesDeaths
Harrison34150535
DeSoto31916399
Hinds31878624
Jackson24352379
Rankin21928388
Lee15450235
Madison14547279
Jones13789241
Forrest13428250
Lauderdale11944315
Lowndes10966185
Lamar10491135
Pearl River9454237
Lafayette8462138
Hancock7703126
Washington7371157
Oktibbeha7118130
Monroe6740174
Warren6656176
Pontotoc6620102
Neshoba6613206
Panola6466131
Marshall6398132
Bolivar6268146
Union596794
Pike5794152
Alcorn5646101
Lincoln5421134
George494979
Scott471198
Tippah466081
Prentiss464881
Leflore4631144
Itawamba4605105
Adams4577119
Tate4553109
Copiah445692
Simpson4423116
Yazoo440386
Wayne438572
Covington427894
Marion4222107
Sunflower4217104
Coahoma4127104
Leake407687
Newton381079
Grenada3700108
Stone358764
Tishomingo358091
Attala330589
Jasper328565
Winston313491
Clay306775
Chickasaw297867
Clarke290694
Calhoun278145
Holmes267287
Smith262450
Yalobusha232847
Tallahatchie225851
Walthall217763
Greene216048
Lawrence211440
Perry204855
Amite204055
Webster201845
Noxubee185940
Montgomery179356
Jefferson Davis170942
Carroll168238
Tunica159039
Benton147538
Kemper141341
Choctaw133026
Claiborne131637
Humphreys129038
Franklin119128
Quitman106328
Wilkinson104539
Jefferson94234
Sharkey64020
Issaquena1937
Unassigned00

Alabama Coronavirus Cases

Cases: 814363

Reported Deaths: 15179
CountyCasesDeaths
Jefferson1141131910
Mobile722941323
Madison52048686
Shelby37315341
Baldwin37098540
Tuscaloosa34973599
Montgomery33996725
Lee23158240
Calhoun22168470
Morgan20675372
Etowah19770496
Marshall18258300
Houston17314405
St. Clair15924337
Cullman15333290
Limestone15239198
Elmore15095284
Lauderdale14163294
Talladega13728272
DeKalb12575259
Walker11096366
Blount10104174
Autauga9904146
Jackson9795180
Coffee9182189
Dale8866181
Colbert8794200
Tallapoosa7045195
Escambia6747127
Covington6688179
Chilton6595160
Russell626358
Franklin5936105
Chambers5562142
Marion4960126
Dallas4897199
Clarke473482
Pike4721105
Geneva4564126
Winston4478101
Lawrence4269117
Bibb421786
Barbour356075
Marengo334189
Monroe330662
Randolph327763
Butler324894
Pickens314082
Henry311265
Hale309487
Cherokee300557
Fayette291079
Washington251151
Cleburne247058
Crenshaw243775
Clay240867
Macon230762
Lamar218146
Conecuh185752
Coosa179038
Lowndes174161
Wilcox167838
Bullock151744
Perry138040
Sumter131138
Greene125844
Choctaw87027
Out of AL00
Unassigned00
Tupelo
Clear
44° wxIcon
Hi: 76° Lo: 45°
Feels Like: 42°
Columbus
Clear
42° wxIcon
Hi: 76° Lo: 43°
Feels Like: 42°
Oxford
Clear
43° wxIcon
Hi: 73° Lo: 41°
Feels Like: 43°
Starkville
Partly Cloudy
41° wxIcon
Hi: 75° Lo: 42°
Feels Like: 41°
Fall like weather has dominated for the last few days, but a slight warming trend will eventually lead to increased rain chances, briefly, by mid-week.
WTVA Radar
WTVA Temperatures
WTVA Severe Weather